An American pharmaceutical company with outstanding development capabilities that they want to keep holding on

Stock prices have been falling since January of this year, but since it is an internationally competitive company, I would like to aim for profit on the assumption of long-term ownership.

　Stock prices have been rising steadily, but they have taken a break and are gaining momentum.

Now, investors in America, or even around the world, are watching with a keen eyeObesity treatment or prevention medicineThat's it. Research institutes such as pharmaceutical companies and universities around the world are competing in the development of drugs to prevent obesity, not only in America.

　Obesity can also cause heart and kidney disease, so I hear that there are many people who want to somehow control obesity. There are drugs that have effects such as suppressing appetite in such people, and if you take them, you can prevent weight gain.

According to recent announcements,Eli LillyIt is said that the investigation revealed that people who used the obesity remedy “Zepbound” for about 8 months returned about half of the weight they lost 1 year after cessation of use.

Nonetheless, it is said that the body weight of those who took the medicine decreased considerably compared to before treatment began. According to a study published in a medical journal, people who used Zepbound for 36 weeks lost 20.9% of their body weight. Those who stopped using it 8 months after starting treatment maintained a weight loss of 9.9% after 88 weeks. It is said that those who did not stop using it succeeded in losing 25.3%.

　(Source: Moomoo Securities MinkaBU PRESS)

In other words, obesity is a chronic challenge, so it is necessary to take medication over a long period of time. There is no seasonality for such drugs, and demand will grow steadily in the future, and it can be expected that demand will increase.

I'll tell you how to use the screener function of the moomoo app to screen the stocks introduced in this article. First, I tried searching for “drugs to treat obesity.”

Then, many stocks were found, as shown in Figure 4.

In order to further narrow down stocks, market = “US stocks,” exchange = “NYSE NASDAQ,”

Theme = “Obesity Treatment Drug Related,” Net Profit - Annual Report ≥0, Operating Profit ≥100 million.

After screening under the above conditions, 4 companies were selected. (Figure 5)